Association of hypothyroidism and polycystic ovarian syndrome: a study in a semi urban area
DOI:
https://doi.org/10.18203/2349-3933.ijam20193102Keywords:
Endocrine disorder, Hypothyroidism, Oligoovulatory infertility, Polycystic ovarian syndrome, Reproductive age, Subclinical hypothyroidismAbstract
Background: Polycystic ovarian syndrome reported to be one of the most common endocrine disorders in the women of the reproductive age, causing oligoovulatory infertility. In many cases, apparently healthy looking women are being diagnosed with either subclinical or overt hypothyroidism after having the symptoms of PCOS. This study was done to analyse the association of PCOS and hypothyroidism in our geographical area.
Methods: 50 women of reproductive ages between 18 to 45 years, who were diagnosed with PCOS, based on Rotterdam’s criteria, 2003 and 50 healthy women as controls, were included into the study. After taking the demographic details from all the patients, they were all subjected to ultrasound for the detection of the cysts. Blood was collected for various biochemical tests including the thyroid profile.
Results: The mean age of all the patients in the study group was 23.6±7.2 compared to 27.1±4.6 of the healthy controls. The Body Mass Index amongst both the groups was 29.1±3.1 and 23.4±2.9 kg/m2 respectively. The levels of thyroid profile were significantly high among the study group with 58%, 54%, 68% as the number of patients with elevated T3, T4 and TSH values. The prevalence of subclinical hypothyroidism was 48.3%, while 51.7% of them had overt hypothyroidism. A higher BMI was found among the patients with PCOS and hypothyroidism.
Conclusion: The prevalence of hypothyroidism among the PCOS patients is certainly on the rise accentuating its association with this endocrine disorder especially among the young adults.
References
Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181-91.
Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol. 1987;1:235-45.
Rebuffé-Scrive M, Cullberg G, Lundberg PA, Lindstedt G, Björntorp P. Anthropometric variables and metabolism in polycystic ovarian disease. Hormone and Metabolic Research. 1989 Jul;21(07):391-7.
Hauner H, Ditschuneit HH, Pal SB, Pfeiffer EF. Distribution of adipose tissue and complications of obesity in overweight women with and without hirsutism. Dtsch Med Wschr. 1987;112:709-13.
Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta ObstetGynecol Scand. 1992;71:599-604.
Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;37:119-25.
Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1985 Nov 1;61(5):946-51.
Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774-800.
Unnikrishnan AG, Kalra S, Sahay RK, Bantwal G, John M, Tewari N. Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India. Ind J Endocrinol Metab. 2013 Jul;17(4):647.
Jansirani A, Ramadevi K. Evaluation of thyroid function status in newly diagnosed polycystic ovarian disease syndrome - An analysis in a tertiary care hospital. National J Basic Medical Sci. 2016;7(2):88-93.
Lamberg BA. Glucose metabolism in thyroid is ease. Acta Medica Scandinavica. 1965;178;351-62.
Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab. 2007;92:4546-56.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;19:41-7.
Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK. Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. Ind J Endocrinol Metabo. 2013 Mar;17(2):304.
Kachuei M, Jafari F, Kachuei A, Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2012;285:853-6.
Fairweather D, Rose NR. Women and autoimmune diseases. Emerging infectious diseases. 2004 Nov;10(11):2005.
Cutolo M, Sulli A, Straub RH. Estrogen metabolism and autoimmunity. Autoimmun Rev. 2012;11:A460-4.
Benetti-Pinto CL, Piccolo VR, Garmes HM, Juliato CR. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters. Fertility and sterility. 2013 Feb 1;99(2):588-92.
Najem F, Elmehdawi R, Swalem A. Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi-Libya; A Retrospective study. Libyan J Med. 2008;3:71-4.
Huang J, Ni R, Chen X, Huang L, Mo Y, Yang D. Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China. Reprod Biol Endocrinol. 2010;17:8-14.
Azevedo MF, Costa EC, Oliveira AI, Silva IB, Marinho JC, Rodrigues JA, et al. Elevated blood pressure in women with polycystic ovary syndrome: Prevalence and associated risk factors. Rev Bras Ginecol Obstet. 2011;33:31-6.
Barcellos CR, Rocha MP, Hayashida SA, Mion Junior D, Lage SG, Marcondes JA. Impact of body mass index on blood pressure levels in patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol. 2007;51:1104-9.
Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril. 2003;79:91-5.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril. 2009;91:456-88.
Anlakash AH. Polycystic ovarian syndrome-the correlation between LH/FSH ratio and disease manifestation. Middle East Fertil Soc J. 2007;12:35-40.
Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo-and hyperinsulinemia. Rocz Akad Med Bialymst. 2003;48:131-4.
Ghosh S, Kabir SN, Pakrashi A, Chatterjee S, Chakravarty B. Subclinical hypothyroidism: A determinant of polycystic ovary syndrome. Horm Res. 1993;39:61-6.
